APA Zitierstil

Faderl, S., Ferrajoli, A., Wierda, W., O'Brien, S., Lerner, S., & Keating, M. J. (2010). Alemtuzumab by Continuous Intravenous Infusion Followed by Subcutaneous Injection Plus Rituximab in the Treatment of Patients With Chronic Lymphocytic Leukemia Recurrence. Cancer.

Chicago Zitierstil

Faderl, Stefan, Alessandra Ferrajoli, William Wierda, Susan O'Brien, Susan Lerner, und Michael J. Keating. "Alemtuzumab By Continuous Intravenous Infusion Followed By Subcutaneous Injection Plus Rituximab in the Treatment of Patients With Chronic Lymphocytic Leukemia Recurrence." Cancer 2010.

MLA Zitierstil

Faderl, Stefan, et al. "Alemtuzumab By Continuous Intravenous Infusion Followed By Subcutaneous Injection Plus Rituximab in the Treatment of Patients With Chronic Lymphocytic Leukemia Recurrence." Cancer 2010.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.